Protective effects of nylidrin and isoproterenol against hemorrhagic shock.
D000818:Animals; D001783:Blood Flow Velocity; D001810:Blood Volume / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D002302:Cardiac Output / Q000187:drug effects; D004285:Dogs; D006400:Hematocrit; D006863:Hydrogen-Ion Concentration; D007545:Isoproterenol / Q000627:therapeutic use*; D008154:Lucanthone / Q000494:pharmacology; D010100:Oxygen / Q000097:blood; D010643:Phenoxybenzamine / Q000494:pharmacology; D012771:Shock, Hemorrhagic / Q000188:drug therapy*; D013566:Sympathomimetics / Q000627:therapeutic use*; D014655:Vascular Resistance / Q000187:drug effects
D013566:Sympathomimetics; D010643:Phenoxybenzamine; D002245:Carbon Dioxide; D008154:Lucanthone; D007545:Isoproterenol; D010100:Oxygen